Stay updated on Nivolumab Combo in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo in Multiple Myeloma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page no longer lists the condition 'Multiple Myeloma' and the related topic 'MedlinePlus Genetics'.
    Difference
    0.1%
    Check dated 2025-12-09T14:22:44.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    These changes are minor metadata updates (revision tag) and removal of non-critical related topics; core study content and eligibility details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:35:26.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Added related topics for Multiple myeloma and MedlinePlus Genetics, and removed a non-critical government funding status notice.
    Difference
    0.2%
    Check dated 2025-11-18T06:55:21.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The topics section no longer includes 'Multiple Myeloma' and the related topic 'MedlinePlus Genetics'. This may affect navigation and discovery of the study by disease and genetics-related topics.
    Difference
    0.1%
    Check dated 2025-11-11T02:23:16.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The Results section has been added, detailing primary and secondary outcomes such as progression-free survival, overall survival, ORR, time to response, and duration of response.
    Difference
    0.2%
    Check dated 2025-11-03T20:57:38.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Added a MedlinePlus Genetics topic covering Multiple myeloma, expanding core content and proper noun coverage.
    Difference
    0.2%
    Check dated 2025-10-13T07:57:30.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Multiple Myeloma Clinical Trial page.